Medicine
Dicyclomine 20 mg tablet
Dicyclomine 20 mg tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Dicyclomine
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 500 tablets and 173 more
- Manufacturers
- Aurobindo PharmaIndiaCamber PharmaceuticalsIndiaNuCare Pharmaceuticals,IncAdvagen PharmaHikma PharmaceuticalsLannettUpsher-Smith LaboratoriesActavis PharmaBionpharmaChartwell RX28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A03AA07 Dicyclomine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 July 1986
- Identifiers
- RxCUI 991086, 991061, 2719470DailyMed set ID c195b8ea-c1bf-453f-e053-2a95a90a2121, 833c5d7c-85ca-4ce3-bcd8-5e5b4ecbffe8, 3b7145d7-1ba7-45c1-8202-b8fc575d5a8e +37NDC 51655-257, 60687-380, 63187-410 +37Application ANDA085223, ANDA040230, ANDA216736 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 176 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 59651-720-01 | Aurobindo PharmaIndia | 25 April 2023 |
| 1000 tablet in 1 bottle | 59651-720-99 | Aurobindo PharmaIndia | 25 April 2023 |
| 100 tablet in 1 bottle | 31722-079-01 | Camber PharmaceuticalsIndia | 7 May 2024 |
| 1000 tablet in 1 bottle | 31722-079-10 | Camber PharmaceuticalsIndia | 7 May 2024 |
| 100 tablet in 1 bottle, plastic | 0054-0885-25 | Hikma Pharmaceuticals | 10 September 2026 |
| 1000 tablet in 1 bottle, plastic | 0054-0885-31 | Hikma Pharmaceuticals | 10 September 2026 |
| 100 tablet in 1 bottle, plastic | 0143-1227-01 | Hikma Pharmaceuticals | 1 October 1996 |
| 1000 tablet in 1 bottle, plastic | 0143-1227-10 | Hikma Pharmaceuticals | 1 October 1996 |
| 100 tablet in 1 bottle, plastic | 0591-0795-01 | Actavis Pharma | 30 July 1986 |
| 1000 tablet in 1 bottle, plastic | 0591-0795-10 | Actavis Pharma | 30 July 1986 |
| 1000 tablet in 1 bottle | 72888-119-00 | Advagen Pharma | 14 December 2022 |
| 100 tablet in 1 bottle | 72888-119-01 | Advagen Pharma | 14 December 2022 |
| 500 tablet in 1 bottle | 72888-119-05 | Advagen Pharma | 14 December 2022 |
| 30 tablet in 1 bottle | 72888-119-30 | Advagen Pharma | 14 December 2022 |
| 100 tablet in 1 bottle, plastic | 69452-311-20 | Bionpharma | 13 September 2023 |
| 1000 tablet in 1 bottle, plastic | 69452-311-32 | Bionpharma | 23 May 2024 |
| 100 tablet in 1 bottle | 62135-428-01 | Chartwell RX | 13 March 2023 |
| 120 tablet in 1 bottle | 62135-428-12 | Chartwell RX | 5 December 2022 |
| 100 tablet in 1 bottle | 0527-1282-01 | Lannett | 26 February 1999 |
| 500 tablet in 1 bottle | 0527-1282-05 | Lannett | 26 February 1999 |
| 1000 tablet in 1 bottle | 0527-1282-10 | Lannett | 26 February 1999 |
| 100 tablet in 1 bottle | 16571-259-01 | Rising Pharma Holdings | 15 November 2024 |
| 1000 tablet in 1 bottle | 16571-259-10 | Rising Pharma Holdings | 15 November 2024 |
| 100 tablet in 1 bottle | 73473-902-01 | Solaris Pharma | 10 June 2025 |
| 1000 tablet in 1 bottle | 73473-902-10 | Solaris Pharma | 10 June 2025 |
| 100 tablet in 1 bottle, plastic | 24979-200-01 | Upsher-Smith Laboratories | 1 July 2023 |
| 500 tablet in 1 bottle, plastic | 24979-200-02 | Upsher-Smith Laboratories | 1 July 2023 |
| 1000 tablet in 1 bottle, plastic | 24979-200-03 | Upsher-Smith Laboratories | 1 July 2023 |
| 10 tablet in 1 bottle | 68071-3255-1 | NuCare Pharmaceuticals | 8 June 2017 |
| 20 tablet in 1 bottle | 68071-3255-2 | NuCare Pharmaceuticals | 8 June 2017 |
| 30 tablet in 1 bottle | 68071-3255-3 | NuCare Pharmaceuticals | 8 June 2017 |
| 15 tablet in 1 bottle | 68071-3255-5 | NuCare Pharmaceuticals | 8 June 2017 |
| 60 tablet in 1 bottle | 68071-3255-6 | NuCare Pharmaceuticals | 8 June 2017 |
| 28 tablet in 1 bottle | 68071-3255-8 | NuCare Pharmaceuticals | 8 June 2017 |
| 90 tablet in 1 bottle | 68071-3255-9 | NuCare Pharmaceuticals | 8 June 2017 |
| 30 tablet in 1 bottle | 68071-3555-3 | NuCare Pharmaceuticals,Inc | 21 December 2023 |
| 60 tablet in 1 bottle | 68071-3555-6 | NuCare Pharmaceuticals,Inc | 21 December 2023 |
| 6 tablet in 1 bottle | 68071-3606-6 | NuCare Pharmaceuticals,Inc | 19 June 2024 |
| 30 tablet in 1 bottle, plastic | 68071-3645-3 | NuCare Pharmaceuticals,Inc | 10 July 2024 |
| 100 tablet in 1 bottle, plastic | 68071-3648-6 | NuCare Pharmaceuticals,Inc | 24 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 May 1950 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dicyclomine
Clinical summary
Dicyclomine is an anticholinergic indicated for the treatment of patients with functional bowel/irritable bowel syndrome. It is available as tablets, capsules and injection for oral and intramuscular use. MedsAcross supplies Dicyclomine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DicyclomineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dicyclomine hydrochloride prescribing information (Advagen Pharma) · U.S. National Library of Medicine, DailyMed
Need Dicyclomine 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.